Диссертация (1139530), страница 35
Текст из файла (страница 35)
– N. 2. –P. 92-98.278. Menezes AM, Hallal PC, Perez-Padilla R, Jardim JR, Muiño A, LopezMV, Valdivia G, Montes de Oca M, Talamo C, Pertuze J, Victora CG forthe Latin American Project for the Investigation of Obstructive LungDisease (PLATINO) Team. Tuberculosis and airflow obstruction: evidencefrom the PLATINO study in Latin America. // Eur Respir J. – 2007. – Vol.30. – N. 6. – P. 1180-1185.279. Miller A, Enright. PFT Interpretive Strategies: American ThoracicSociety/Europian Respiratory Society 2005 Guidelines Gaps.
// RespirCare. – 2012. – Vol. 57. – N. 1. – P. 127-133.280. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A,Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, JohnsonDC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, ViegiG, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. // EurRespir J.
– 2005. – Vol. 26. – N. 2. – P. 319-338.281. Miller MR, Quanjer PH, Swanney MP, Ruppel G, Enright PL.Interpreting lung function data using 80% predicted and fixed thresholdsmisclassifies more than 20% of patients. // Chest. – 2011. – Vol. 139. – N.1. – P. 52-59.282. Myrdal G, Valtysdottir S, Lambe M and Stahle E. Quality of lifefollowing lung cancer surgery. // Thorax. – 2003. - Vol. 58. – N.3. – P.194-197.283. Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Tauleria E,Sanchez G, Sobradillo V, Ancochea J. Prevalence of COPD in Spain:279impact of undiagnosed COPD on quality of life and daily life activities. //Thorax.
– 2009. – Vol. 64. – N. 10. – P. 863-868.284. Nelson SB, LaVange LM, Nie Y, Walsh JW, Enright PL, Martinez FJ,Mannino DM, Thomashow BM. Questionnaires and pocket spirometersprovide an alternative approach for COPD screening in the generalpopulation. // Chest. – 2012. – Vol. 142. – N. 2. –P.
358-366.285. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J,Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, GosselinkR, Lareau S, MacIntyre N, Maltais F, Morgan M, O'Donnell D, Prefault C,Reardon J, Rochester C, Schols A, Singh S, Troosters T; ATS/ERSPulmonary Rehabilitation Writing Committee.Society/EuropeanRespiratorySocietyAmerican Thoracicstatementonpulmonaryrehabilitation. // Am J Respir Crit Care Med. – 2006. – Vol. 173.
– N. 12. –P. 1390-1413.286. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictorof 5-year survival than airway obstruction in patients with COPD. // Chest.– 2002. – Vol. 121 – N. 5. - P. 1434-1440.287. Norman GR, Wyrwich KW, Patrick DL. The mathematical relationshipamong different forms of responsiveness coefficients. // Qual Life Res. –2007. – Vol. 16. – N. 5. - P. 815–822.288. Norman GR, Streiner DL. Do CIs give you confidence? // Chest.
– 2012.– Vol. 141. N. 10. – P. 17-19.289. Nugent A-M, Steele IC, Carragher AM, McManus K, McGuigan JA,Gibbons JRP, Riley MS, Nicholls DP. Effect of thoracotomy and lungresection on exercise capacity in patients with lung cancer. // Thorax. –1999. – Vol. 54. – N. 4. – P. 334–338.290. O’Connor GT, Anderson KM, Kannel WB, Brand FN, Christiansen JC,Weiss ST, Speizer FE. Prevalence and prognosis of dyspnea in theFramingham study.
// Chest. – 1987. – Vol. 92. – N. 2. - P. 90s.280291. O’Connor TM, O'Riordan DM, Stack M, Bredin CP. Airwaysobstruction in survivors of thoracoplasty. // Respirology. – 2004. – Vol. 9.– N. 1. - P. 130-133.292. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of thefactors related to mortality in chronic obstructive pulmonary disease: roleof exercise capacity and health status. // Am J Respir Crit Care Med. –2003. – Vol. 167.
– N. 4. - P. 544–549.293. Ohar JA, Sadeghnejad A, Meyers DA, Donohue JF, Bleecker ER. Dosymptoms predict COPD in smokers? // Chest. – 2010. – Vol. 137. – N. 6.– P. 1345-53.294. Olsen GN and Block AJ. Physiology of lung resection. In Spittell JA Jr.Clinical Medicine. Harper&Row, Publishers, Philadelphia, 1985.295.
Olofson J, Skoogh BE, Bake B, Svärdsudd K. Mortality related tosmoking habits, respiratory symptoms and lung function. // Eur J RespirDis. – 1987. – Vol. 71. – N. 2. – P. 69-76.296. Ong KC, Wong WP, Jailani AR, Sew S, Ong YY. Effect of a pulmonaryrehabilitation program on physiologic and psychosocial outcomes inpatients with chronic respiratory disorders. // Ann Acad Med Singapore.
2001. - Vol. 30. - N. 1. - P. 15-21.297. Palange P, Ward SA, Carlsen KH, et al.ERS Task Force.Recommendations on the use of exercise testing in clinical practice. // EurRespir J. – 2007. – Vol. 29. – N.1. – P. 185-209.298. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL,Bourbeau J, Calverley PM, Gift AG, Harver A, Lareau SC, Mahler DA,Meek PM, O'Donnell DE; American Thoracic Society Committee onDyspnea. An official American Thoracic Society statement: update on themechanisms, assessment, and management of dyspnea. // Am J Respir CritCare Med.
– 2012. – Vol. 185. – N. 4. – P. 435-452.281299. Pasipanodya JG, Miller TL, Vecino M, Munguia G, Bae S, Drewyer Gand Weis SE. Using the St. George respiratory questionnaire to ascertainhealth quality in person with treated pulmonary tuberculosis. // Chest. –2007. - Vol. 132. – N. 5. - P. 1591-1598.300. Pasipanodya JG, Vecino E, Miller TL, Munguia G, Drewyer G,Fernandez M, Slocum P and Weis SE. Non-hispanic whites have higherrisk for pulmonary impairment from pulmonary tuberculosis. // BMCPublic Health.
– 2012. – Vol. 12. – P. 119.301. Pedersen F, Mehlsen J, Raymond I, Atar D, Skjoldborg US, HildebrandtPR. Evaluation of dyspnoea in a sample of elderly subjects recruited fromgeneral practice. // Int J Clin Pract. – 2007. – Vol. 61. – N. 9. – P. 14811491302. Pelkonen M, Tukiainen H, Tervahauta M, Notkola IL, Kivelä SL,Salorinne Y, Nissinen A. Pulmonary function, smoking cessation and 30year mortality in middle aged Finnish men. // Thorax.
– 2000. – Vol. 55. –N. 9. – P. 746-750.303. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R,Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R,Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF,Wanger J . Interpretative strategies for lung function tests. // Eur Respir J. –2005. – Vol. 26. – N. 5. – P. 948-968.304. Perez-Padilla R, Vollmer WM, Vázquez-García JC, Enright PL,Menezes AM, Buist AS; BOLD and PLATINO Study Groups. Can anormal peak expiratory flow exclude severe chronic obstructive pulmonarydisease? // Int J Tuberc Lung Dis. – 2009.
- Vol. 13. – N. 3. – P. 387-393.305. Pettit AC, Kaltenbach LA, Maruri F, Cummins J, Smith TR, WarkentinJV, Griffin MR, Sterling TR. Chronic lung disease and HIV infection arerisk factors for recurrent tuberculosis in a low-incidence setting. // Int JTuberc Lung Dis.
– 2011. – Vol. 15. – N. 7. – P. 906-911.282306. Pinto-Plata VM, Cote C, Cabral H, et al. The 6-min walk distance:change over time and value as a predictor of survival in severe COPD. //Eur Respir J. – 2004. – Vol. 23. – N. 1. – P. 28-33.307. Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activitymonitoring for assessment of physical activities in daily life in patients withchronic obstructive pulmonary disease. // Arch Phys Med Rehabil. – 2005.– Vol. 86.
– N. 10. - P. 1979-1985.308. Phillips MS, Kinnear WJ, Shneerson JM. Late sequelae of pulmonarytuberculosis treated by thoracoplasty. // Thorax. – 1987. – Vol. 42. – N. 6. –P. 445-451.309. Plit ML, Anderson R, Van Rensburg CEJ, Page-Snipp L, Blott JA,Fresen JL, Feldman C. Influence of antimicrobial chemotherapy onspirometric parameters and pro-inflammatory indices in severe pulmonarytuberculosis.
// Eur Respir J. – 1998. - Vol. 12. - N.2. – P. 351-356.310. Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V,Vestbo J, Calverley PM, Tal-Singer R, Agustí A, Bakke PS, Coxson HO,Lomas DA, MacNee W, Rennard S, Silverman EK, Miller BE, Crim C,Yates J, Wouters EF, Celli B; Evaluation of COPD Longitudinally toIdentify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators.Six-minute-walk test in chronic obstructive pulmonary disease: minimalclinically important difference for death or hospitalization.
// Am J RespirCrit Care Med. – 2013. – Vol.187. – N.4. – P.382-386.311. Prescott E, Vestbo J. Socioeconomic status and chronic obstructivepulmonary disease. // Thorax. – 1999. – Vol. 54. – N. 8. – P. 737-741.312. Pride NB. Tests of forced expiration and inspiration. // Clin Chest Med. 2001. - Vol. 22. –N.4. – P. 599-622.313. Puhan MA, Mador MJ, Held U, et al. Interpretation of treatment changesin 6-minute walk distance in patients with COPD. // Eur Respir J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
